Before PDUFA was passed, the drug approval process was notoriously slow. The average drug would take between 21 and 29 months to be reviewed. Now, the FDA’s target is between six to 10 months.
Continue reading...
，这一点在雷电模拟器官方版本下载中也有详细论述
20+ curated newsletters
Екатерина Щербакова (ночной линейный редактор)